Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 2/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | ULK1 | O75385 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13327603 | 0.82 | AR (0.43) | TDP1NR1H2NR1H3RAB9ASMN1; SMN2 | |
| SCHEMBL3147240 | 0.81 | TDO2 (0.44) | ADORA2ANR1H2NR1H3KDM4ERAB9A | |
| SCHEMBL10300877 | 0.74 | ADORA2A (0.50) | CYP11B2CYP11B1ADORA2AKDM4ERAB9A | |
| SCHEMBL4154540 | 0.74 | CYP11B1 (0.50) | CYP11B2CYP11B1ADORA2ATDP1KDM4E | |
| SCHEMBL12337987 | 0.73 | SSTR4 (0.42) | NR1H2NR1H3RAB9ABACE1ALDH1A1 | |
| SCHEMBL26092182 | 0.73 | ULK1 (0.39) | CYP11B2CYP11B1NR1H2NR1H3SMN1; SMN2 | |
| SCHEMBL3147045 | 0.73 | PIK3CD (0.40) | CYP11B2CYP11B1NR1H2NR1H3BACE1 | |
| SCHEMBL25428909 | 0.71 | MAPT (0.50) | TDP1ALDH1A1NPSR1 | |
| SCHEMBL2404786 | 0.71 | ADORA2A (0.44) | CYP11B2ADORA2ATDP1KDM4ERAB9A | |
| SCHEMBL1334325 | 0.71 | ADORA1 (0.58) | ADORA2AADORA1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1348711-B1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KK (JP) | 2018-06-13 | — | — | EP | disclosed |
| EP-1889891-B1 | Luminescence device and display apparatus | CANON KK (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-20150076478-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KK (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8920943-B2 | Luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2014-12-30 | — | — | US | disclosed |
| US-7687155-B2 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2010-03-30 | — | — | US | disclosed |
| US-20090184634-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-07-23 | — | — | US | disclosed |
| US-7544426-B2 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2009-06-09 | — | — | US | disclosed |
| US-7527879-B2 | Luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| CN-100375749-C | Luminescence device and display apparatus | CANON KK (JP) | 2008-03-19 | — | — | CN | disclosed |
| EP-1889891-A2 | Luminescence device and display apparatus | Canon Kabushiki Kaisha (JP) | 2008-02-20 | — | — | EP | disclosed |
| EP-1881050-A2 | Luminescence device and display apparatus | Canon Kabushiki Kaisha (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-20070216294-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070212570-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2007-09-13 | — | — | US | disclosed |
| US-7147935-B2 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2006-12-12 | — | — | US | disclosed |
| CN-1285601-C | Light emitting device and display | CANON KK (JP) | 2006-11-22 | — | — | CN | disclosed |
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2006-08-10 | — | — | US | disclosed |
| CN-1781925-A | Luminescence device and display apparatus | CANON KK (JP) | 2006-06-07 | — | — | CN | disclosed |
| CN-1474826-A | Light emitting device and display | ������������ʽ���� | 2004-02-11 | — | — | CN | disclosed |
| EP-1348711-A1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KABUSHIKI KAISHA (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030068526-A1 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | AP3M1, MLEC, MLX | CYP11B2 3389/4885CYP11B1 3892/4885ADORA2A 4502/4885 |
| US-20090184634-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | SOD1, NLRP1, LUC7L2 | CYP11B2 3728/4885CYP11B1 3868/4885ADORA2A 1882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.